Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.
This study has been completed.
Study NCT00309166 Information provided by GlaxoSmithKline
First Received on March 28, 2006. Last Updated on November 21, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prophylaxis HPV Infection
Interventions listed in this trial
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers